デフォルト表紙
市場調査レポート
商品コード
1732840

前臨床イメージング市場-世界の産業規模、シェア、動向、機会、予測、モダリティ別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

Preclinical Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality, By Application, By End User, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 183 Pages
納期
2～3営業日
カスタマイズ可能
前臨床イメージング市場-世界の産業規模、シェア、動向、機会、予測、モダリティ別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年
出版日: 2025年05月23日
発行: TechSci Research
ページ情報: 英文 183 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

前臨床イメージングの世界市場規模は2024年に51億3,000万米ドルとなり、2030年までには72億7,000万米ドルに達し、予測期間中のCAGRは5.94%で成長すると予測されています。

前臨床イメージングは、生物医学研究の重要な要素であり、動物モデルにおける生物学的プロセスを可視化・モニタリングする非侵襲的技術を提供します。これにより、科学者は疾患の進行を研究し、薬効を評価し、個別化医療戦略を開発することができます。この市場は、創薬への投資の増加、初期段階の疾患研究に対する需要の増加、慢性疾患の蔓延の増加により急速に拡大しています。MRI、PET、CT、光イメージングなどのモダリティは、これらのアプリケーションで中心的な役割を果たしています。イメージング技術の統合、イメージング分解能とデータ解析の進歩により、研究能力はさらに向上しています。医療イノベーションを加速させる前臨床イメージングの価値に対する世界の認識の高まりは、予測期間中も市場の勢いを維持すると予想されます。

市場概要
予測期間 2026年～2030年
市場規模：2024年 51億3,000万米ドル
市場規模：2030年 72億7,000万米ドル
CAGR：2025年～2030年 5.94%
急成長セグメント 創薬
最大市場 北米

主要な市場促進要因

侵襲的な手技を必要とせずに、疾患の進行、薬剤の有効性、生物学的プロセスの詳細なメカニズムを観察できる能力があると推測します。

主要な市場課題

技術とインフラのコスト

主要な市場動向

マルチモーダルイメージングの統合

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の前臨床イメージング市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • モダリティ別（光学イメージングシステム、核イメージングシステム、マイクロMRI、マイクロ超音波、マイクロCT、光音響イメージングシステム、その他）
    • 用途別（研究開発、創薬）
    • エンドユーザー別（バイオテクノロジー・製薬企業、学術・調査機関、その他）
    • 地域別
    • 企業別（2024年）
  • 市場マップ

第6章 北米の前臨床イメージング市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 用途別
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の前臨床イメージング市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン

第8章 アジア太平洋の前臨床イメージング市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の前臨床イメージング市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの前臨床イメージング市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第13章 世界の前臨床イメージング市場：SWOT分析

第14章 競合情勢

  • Aspect Imaging Ltd
  • Bruker Corporation
  • Fujifilm Holdings Corporation
  • Mediso Ltd
  • MR Solutions Ltd
  • PerkinElmer Inc.
  • United Imaging Healthcare Co. Ltd
  • AXT PTY LTD
  • Advanced Molecular Vision, Inc.
  • IVIM Technology Corp.Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 16126

The Global Preclinical Imaging Market was valued at USD 5.13 billion in 2024 and is projected to reach USD 7.27 billion by 2030, growing at a CAGR of 5.94% during the forecast period. Preclinical imaging is a critical component of biomedical research, offering non-invasive techniques to visualize and monitor biological processes in animal models. This enables scientists to study disease progression, evaluate drug efficacy, and develop personalized medicine strategies. The market is expanding rapidly due to rising investment in drug discovery, increasing demand for early-stage disease research, and the growing prevalence of chronic conditions. Modalities such as MRI, PET, CT, and optical imaging play a central role in these applications. The integration of imaging technologies and advancements in imaging resolution and data analysis are further enhancing research capabilities. Increased global awareness of the value of preclinical imaging in accelerating medical innovation is expected to sustain strong market momentum over the forecast period.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.13 Billion
Market Size 2030USD 7.27 Billion
CAGR 2025-20305.94%
Fastest Growing SegmentDrug Discovery
Largest MarketNorth America

Key Market Drivers

Imagine having the ability to witness disease progression, drug efficacy, and the intricate details of biological processes without invasive procedures.

This is the transformative promise of preclinical imaging. Techniques such as MRI, PET, and CT scans offer unparalleled insights into disease mechanisms, treatment effects, and biological responses in real time. These technologies have become indispensable tools across medical research fields, including oncology, cardiology, and neurology. Their utility in visualizing tissue response and pharmacokinetics contributes to faster and more effective drug development. As the demand for targeted therapies and personalized medicine grows, so does the reliance on sophisticated imaging systems that can provide early and accurate biological assessments, propelling the growth of the preclinical imaging market globally.

Key Market Challenges

Cost of Technology and Infrastructure

The high cost of acquiring, maintaining, and operating advanced imaging equipment remains a significant barrier in the preclinical imaging space. Technologies like MRI, PET, and CT scanners involve substantial capital investment, which can be prohibitive for small and mid-sized research facilities. Additionally, ongoing maintenance, software upgrades, and the need for highly skilled personnel add to the financial burden. According to a 2024 NIH report, over 45% of life science laboratories identified training and equipment maintenance as major financial challenges. These cost-related issues can limit access to cutting-edge imaging tools, thereby constraining innovation and adoption in emerging and resource-limited markets.

Key Market Trends

Multi-Modal Imaging Integration

A key trend in the Global Preclinical Imaging Market is the growing adoption of multi-modal imaging systems. By integrating technologies like MRI, PET, CT, and optical imaging, researchers can simultaneously obtain anatomical, functional, and molecular data. Each modality offers unique strengths: for example, MRI provides high-resolution anatomical detail, while PET allows for the visualization of metabolic processes. The combination of these approaches enables a more comprehensive analysis, improving the depth and accuracy of preclinical studies. As integration technology becomes more cost-effective and accessible, multi-modal imaging is expected to become a standard in research environments seeking to maximize data quality and operational efficiency.

Key Market Players

  • Aspect Imaging Ltd
  • Bruker Corporation
  • Fujifilm Holdings Corporation
  • Mediso Ltd
  • MR Solutions Ltd
  • PerkinElmer Inc.
  • United Imaging Healthcare Co. Ltd
  • AXT PTY LTD
  • Advanced Molecular Vision, Inc.
  • IVIM Technology Corp

Report Scope

In this report, the Global Preclinical Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Preclinical Imaging Market, By Modality:

  • Optical Imaging Systems
  • Nuclear Imaging Systems
  • Micro-MRI
  • Micro-ultrasound
  • Micro-CT
  • Photoacoustic Imaging Systems
  • Other

Preclinical Imaging Market, By Application:

  • Research and Development
  • Drug Discovery

Preclinical Imaging Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Others

Preclinical Imaging Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Preclinical Imaging Market.

Available Customizations

Global Preclinical Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Preclinical Imaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-ultrasound, Micro-CT, Photoacoustic Imaging Systems, Other)
    • 5.2.2. By Application (Research and Development, Drug Discovery)
    • 5.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Preclinical Imaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Modality
  • 6.2.2 By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Preclinical Imaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Modality
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Preclinical Imaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Modality
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Preclinical Imaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Modality
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Preclinical Imaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Modality
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Preclinical Imaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Modality
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Preclinical Imaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Modality
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Preclinical Imaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Modality
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Preclinical Imaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Modality
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Preclinical Imaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Modality
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Preclinical Imaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Modality
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Preclinical Imaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Modality
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Preclinical Imaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Modality
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Preclinical Imaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Modality
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Preclinical Imaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Modality
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Preclinical Imaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Modality
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Preclinical Imaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Modality
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Preclinical Imaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Modality
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Preclinical Imaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Modality
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Preclinical Imaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Modality
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Preclinical Imaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Modality
    • 10.2.1 By Application
    • 10.2.2.By End User
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Preclinical Imaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Modality
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Preclinical Imaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Modality
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Preclinical Imaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Modality
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Preclinical Imaging Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Aspect Imaging Ltd
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Bruker Corporation
  • 14.3. Fujifilm Holdings Corporation
  • 14.4. Mediso Ltd
  • 14.5. MR Solutions Ltd
  • 14.6. PerkinElmer Inc.
  • 14.7. United Imaging Healthcare Co. Ltd
  • 14.8. AXT PTY LTD
  • 14.9. Advanced Molecular Vision, Inc.
  • 14.10 IVIM Technology Corp.Inc.

15. Strategic Recommendations

16. About Us & Disclaimer